Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor
Alison M. Motley(University of Cambridge), Ben Distel(Academic Medical Center), Pedro Brites(Instituto de Biologia Molecular e Celular), Henk F. Tabak(University of Amsterdam), Ewald H. Hettema(University of Amsterdam), Frank Baas(The Netherlands Cancer Institute), Eveline M. Hogenhout(University of Amsterdam), Ronald J. A. Wanders(University of Amsterdam), Frits A. Wijburg(Emma Kinderziekenhuis), Hugo S.A. Heijmans(University of Amsterdam), Anneloor L.M.A. ten Asbroek(University of Amsterdam)
Cited by 272
Related Papers
Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies
|Nature Medicine|2014|838
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
|Proceedings of the National Academy of Sciences|2008|725
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia
|Orphanet Journal of Rare Diseases|2014|713
Clathrin-mediated endocytosis in AP-2–depleted cells
|The Journal of Cell Biology|2003|693
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
|Proceedings of the National Academy of Sciences|1994|691